Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.122 USD | +0.56% | -13.04% | +20.56% |
03-14 | Top Premarket Gainers | MT |
03-13 | Indaptus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Newman
FOU | Founder | 68 | 23/02/21 |
Jeffrey Meckler
CEO | Chief Executive Officer | 57 | 02/08/21 |
Nir Sassi
DFI | Director of Finance/CFO | 48 | 30/06/21 |
Roger Waltzman
CTO | Chief Tech/Sci/R&D Officer | 56 | 06/08/23 |
Walt Linscott
COO | Chief Operating Officer | 63 | 30/06/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Hayes
BRD | Director/Board Member | 58 | 02/08/21 |
Jeffrey Meckler
CEO | Chief Executive Officer | 57 | 02/08/21 |
Director/Board Member | 61 | 12/01/23 | |
Hila Karah
BRD | Director/Board Member | 55 | 30/06/21 |
Michael Newman
FOU | Founder | 68 | 23/02/21 |
Roger Pomerantz
CHM | Chairman | 67 | 31/07/21 |
Director/Board Member | 71 | 30/06/21 | |
Mark Gilbert
BRD | Director/Board Member | 63 | 31/10/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,538,883 | 5,902,783 ( 69.13 %) | 0 | 69.13 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.56% | 18.02M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- INDP Stock
- Company Indaptus Therapeutics, Inc.